Anavex Life Sciences : Announces Issuance of New U.S. Patent ANAVEX®2-73 (blarcamesine)

Intellectual Property Portfolio for the Treatment of Hypertension


Anavex Life Sciences Corp. , a clinical-stage biopharmaceutical company developing... | May 1, 2023

Related Keywords

United States ,Christopheru Missling ,Andrewj Barwicki , ,Linkedin ,Instagram ,Twitter ,Trademark Office ,Michaelj Fox Foundation For Parkinson Research ,Facebook ,Company Nasdaq ,Research Business Development ,Anavex Life Sciences Corp ,Nasdaq ,Us Centers For Disease ,Intellectual Property Portfolio ,Life Sciences ,United States Patent ,Chief Executive Officer ,High Blood Pressure ,Disease Control ,Annual Report ,Anavex Life Sciences ,Further Information ,Investor Relations Tel ,Rev Cardiovasc ,Anavex Life Sciences Corp Stock Exchange ,News ,Information ,Press Release ,Intellectual ,Property ,Portfolio ,Or ,The ,Treatment ,F ,Navex ,Life ,Ciences ,Iopharmaceutical ,Ompany Avxl Us0327973006 ,